SAN DIEGO — In this exclusive video from ASN Kidney Week 2018, Ian Sabir, June Zhao, MD, PhD and Ayman Al-Shurbaji, MD, PhD, discuss a phase III study that compared 5 g and 10 g of Lokelma (sodium zirconium cyclosilicate, AstraZeneca) with placebo for the treatment of hyperkalemia.
No commercial support for this activity.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.